A federal judge in Illinois has tripled the amount Eli Lilly must pay after a jury found the pharmaceutical company guilty of violating the False Claims Act in August 2022.
Eli Lilly and Co. has asked an Illinois federal judge to unwind a jury's $61 million verdict in a whistleblower's suit claiming the drug company intentionally shorted Medicaid on drug rebates, arguing the whistleblower can't prove the company knowingly violated the law.
Lilly to pay more than $180mn for defrauding US Medicaid Program europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
An Illinois federal jury hit Eli Lilly and Co. with a $61 million verdict Wednesday after finding that the drug manufacturer deliberately shorted the Medicaid program by leaving retroactive drug price increases out of the metrics it was required to include for drug rebate calculations.